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Abstract
Background: Australia is considering implementing a chlamydia screening program in general
practice. The views of general practitioners (GPs) are necessary to inform the design of the
program. This paper aimed to investigate Australian GPs' views on how chlamydia screening could
work in the Australian context.
Methods: This project used both qualitative interviews and a quantitative questionnaire. GPs were
randomly selected from a national database of medical practitioners for both the qualitative and
quantitative components. Semi-structured interviews were conducted with GPs and a thematic
analysis conducted. The results of the interviews were used to design a quantitative postal
questionnaire for completion by a larger sample of GPs. Up to three reminders were sent to non-
responders.
Results: Twenty one GPs completed an interview and 255 completed the postal questionnaire.
The results of the postal survey were in strong concordance with those of the interview. GPs
identified a number of barriers to increased screening including lack of time, knowledge of GPs and
the public about chlamydia, patient embarrassment and support for partner notification. GPs felt
strongly that screening would be easier if there was a national program and if the public and GPs
had a greater knowledge about chlamydia. Incentive payments and mechanisms for recall and
reminders would facilitate screening. Greater support for contact tracing would be important if
screening is to increase.
Conclusion: Chlamydia screening in general practice is acceptable to Australian GPs. If screening
is to succeed, policy makers must consider the facilitators identified by GPs.
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Chlamydia trachomatis infection is the most commonly
notified sexually transmissible infection (STI) in Aus-
tralia, with over 50,000 infections notified in 2007 (244
per 100,000 population) [1]. Australian data show the
greatest burden of chlamydia infection is among young
women aged 15 to 24 years with a prevalence of about 3–
4% among this age group [2,3]. Infection with chlamydia
can have serious consequences, particularly for women.
Up to two thirds of cases of tubal infertility and one third
of cases of ectopic pregnancy are potentially attributable
to past chlamydia infection [4].
Many countries around the world already have screening
programs in place including Sweden [5] and the United
Kingdom [6] and others including the Netherlands [7],
Denmark [7] and Australia [8] are still considering how
best to implement screening.
In its first National Sexually Transmissible Infections
Strategy released in 2005 [9], the Australian Common-
wealth Government stated that a chlamydia screening
pilot program targeting sexually active young people
under 25 years of age should be a priority action. In
response, it announced in 2007 that it would evaluate a
chlamydia screening pilot program set in general practice;
the design of this program is currently under development
[10]. Unlike general practice in the United Kingdom, peo-
ple in Australia are not required to register with a single
clinic, but can attend several different clinics. However,
general practitioners (GPs) in Australia are ideally placed
to conduct widespread chlamydia screening as nearly 90%
of Australian women aged 15–24 years of age, the key risk
group,[4] visit a GP at least once each year [11], and the
many specialist youth, family planning and STI clinics
and outreach screening programs targeting the homeless
and marginalized populations help to reach the remain-
ing 10% [12-14].
Successful programs require support from both the pro-
fessionals who will undertake the screening and the target
group to be screened [15]. As GPs are likely to be conduct-
ing the vast majority of chlamydia tests, it is vital that their
opinions are sought before planning a chlamydia screen-
ing program in Australia. This study aimed to determine
GPs' views on how chlamydia screening could work in the
Australian context.
Methods
This study included both qualitative and quantitative
components and was conducted in Victoria (population 5
million), a State of Australia during 2005 and 2006. The
results of the qualitative interviews were used to design a
self-administered questionnaire that aimed to explore the
findings of the interviews on a larger sample of GPs. We
were careful to balance individual or discipline bias in
assembling our research team: an experienced sexual
health and infectious diseases physician, two practising
GPs with academic experience, a sociologist with expertise
in qualitative research and an epidemiologist with a par-
ticular interest in chlamydia infection.
Qualitative – semi-structured interviews
A random selection of 1,000 GPs in Victoria (minimum
sample size available for purchase) was acquired from the
Australian Medical Publishing Company's (AMPCo)
national database of medical practitioners [16]. This sam-
ple of 1000 was stratified by geographical location pro-
portional to population size, based on GP postcode (rural
versus metropolitan) and a random sample of 70 GP
names selected proportionately across these strata, was
taken to ensure that both rural and metropolitan GPs
were invited to participate. They were considered eligible
to be interviewed if they were currently practising as a GP
in Victoria.
RP conducted all interviews face to face, following a semi-
structured form. As annual screening for young women is
currently recommended in Australia [17], the interviews
focused on screening among young women, although we
acknowledge the importance of including men in screen-
ing. Recruitment continued until saturation of emerging
themes was evident during the interviews. The interview
schedule was devised with input from all members of our
multi-disciplinary research team and was informed by
current knowledge and policy about chlamydia control.
Interviews were transcribed verbatim and imported into
NVivo7. We applied a thematic analysis and looked for
emerging themes [18]. NP and RP read all transcripts,
worked on the thematic analysis separately and met to
discuss emerging themes. The coding framework devel-
oped from these discussions. NP and RP reviewed emerg-
ing themes as the analysis progressed. We attempted to
avoid bias in interpreting the data by having both RP and
NP active in reviewing the transcripts, eliciting themes
and formulating our analysis.
Quantitative – postal questionnaire
The postal questionnaire was pilot tested among a sample
of eight medical practitioners known to the study investi-
gators prior to administration. Assuming a response rate
of 50%, a sample size of 300 would give 95% confidence
intervals around a proportion of 50% from 44% to 56%.
On this basis, a further random sample of 600 GPs was
selected from the 1000 sample described above. GPs were
sent a letter of invitation, a copy of the questionnaire and
a reply paid envelope. Up to three reminders were sent to
non-responding GPs. The postal questionnaire was ana-
lysed using Stata version 9 [19].Page 2 of 8
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Ethics approval for this project was obtained from the
University of Melbourne Human Research Ethics Com-
mittee.
Results
In-depth interviews were conducted with 21 GPs (30% of
those contacted) – 13 GPs interviewed were in urban prac-
tices and eight in rural and regional practices, eight were
female. Of the 600 GPs selected to complete the postal
questionnaire, 543 were confirmed to be still practicing in
general practice and 255 participated with a response rate
of 47%. Female GPs [45.9% (95%CI: 39.6%, 52.2%)] and
older GPs [mean age 49.8 years (95%CI: 48.7 years, 50.9
years)] were more likely to complete the postal question-
naire compared with the whole Victorian GP population
(35.4% female GPs, mean age = 47.7 years) [20]. The
results of these two studies are presented together for each
issue investigated.
GPs' attitudes to screening
Qualitative component
There was overwhelming support for screening amongst
those interviewed; GPs felt that general practice was an
appropriate site for screening. Opportunistic screening for
chlamydia during a sexual health consultation was the
preferred model with most mentioning the Pap test (cer-
vical smear) as an opportune time to conduct a chlamydia
test. Other GPs mentioned screening when symptoms are
present or during a sexual health consultation (other than
the Pap test):
Yes, I think it should take place in general practice, because I
think if we're aiming at young women ... ..... that's who they're
going to come in contact with... on a first line basis. (DC13)
... at the moment it's marketed with STD checks, which people
often come and do. I think that's one way to do it, to offer with
STD checks. (DC20)
Quantitative component
The postal questionnaire revealed similar results to those
obtained during the interviews. GPs believed chlamydia
screening is a GP's responsibility: 90% of respondents dis-
agreed with the statement "Chlamydia testing should NOT
be the responsibility of GPs" and 95% disagreed with the
statement "Chlamydia testing should only be undertaken in
family planning or sexual health clinic''. Table 1 shows that
when GPs were asked to select just one preferred option,
about one third believed chlamydia screening should be
associated with a sexual health consultation and another
third believed an organised chlamydia screening program
similar to the National Cervical Screening Program with a
register for recall and reminders should be introduced.
Only one percent of respondents indicated that they did
not think there was need for a chlamydia screening pro-
gram in Australia.
Barriers and facilitators of screening for chlamydia
Qualitative component
GPs were asked to identify any barriers that would impact
on screening for chlamydia in general practice and any
facilitators that might help overcome these barriers.
a) Barriers
The barriers most often mentioned were GP workload,
time and cost. These issues were linked to the administra-
tive side of screening – discussing chlamydia and its pos-
sible consequences with patients and conducting follow
up:
General practitioners are under the pump at the moment time wise, 
we have very little time. And that's not going to change. (DC07)
Lack of knowledge amongst GPs about chlamydia and the
discomfort that some may feel in dealing with sexual
health matters was also mentioned as a barrier to chlamy-
dia screening. Some commented that GPs sometimes do
not communicate well with patients and that discussing
sensitive issues requires tact.
I don't think sexual history taking is taught well at medical
school for a start. I think how to investigate for any sort of STIs
are seen as a sort of scary. And many GPs don't have, perhaps
don't even realise that a urine sample is good enough. So I think
there needs to be more education targeted towards preparing
GPs for this sort of work, and increasing their knowledge. And
also their own self confidence. (DC13)
They don't want to umm, know about it and it takes a lot of tact
if you're actually screening to not sort of dump the other partner
Table 1: Preference for chlamydia screening
Statement % (95%CI)
An opportunistic screening program capturing eligible people when they present to a GP for any reason. 25 (20, 31)
An opportunistic screening program capturing eligible people when they present to a GP for a sexual health reason (e.g.: Pap smear, 
contraception advice).
36 (30, 42)
An organised screening program similar to the Pap smear or breast-screening program with a system of invitation, recall and 
reminders.
38 (32, 44)
There is no need for a chlamydia screening program in Australia 1 (0, 3)Page 3 of 8
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(DC09)
GPs interviewed perceived chlamydia screening as a diffi-
cult topic to raise and discuss in general practice and wor-
ried that patients may feel insulted that they are being
asked to test for a STI:
But I think the biggest thing with sexually transmitted illnesses
is the problem of, if someone's supposed to be in a stable rela-
tionship they can take that as an affront you know that you sug-
gest that maybe you should be screened for sexually transmitted
illnesses. (DC09)
Patient embarrassment about STIs and patients' lack of
knowledge about chlamydia were also seen as important
barriers to screening. A further barrier identified was
patient reluctance to respond to recalls for treatment or
follow up. The administrative burden of this kind of sys-
tem was felt to add to the cost and workload of a practice:
..what do you do with people who ignore your recalls? So at the
moment say for instance with our smear test, we send out two
or three, I think it's, two reminders and then a third reminder
comes with registered mail saying, you know, please take notice,
that's the last one you're getting, rather than sending them out
every month for ever, and people just don't take any notice.
(DC09)
Religious and cultural issues were also mentioned as pos-
sible barriers to screening and an area that would need to
be addressed in a sensitive and culturally appropriate way.
It was also suggested that some women will prefer to see a
female GP for chlamydia screening.
b) Facilitators
Education of GPs and their practice staff was seen as
important to facilitating chlamydia screening in general
practice. Some GPs identified adequate financial incen-
tives as a factor that would facilitate the implementation
of chlamydia screening. A national approach to screening
with national guidelines would also support screening:
..if the health Department came out and the umm, College of
Gynaecology that it was appropriate to screen women you know,
every two years or every twelve months, then we would run with
that recommendation.(DC07)
Broad community education and destigmatization of
chlamydia were thought to be essential prior to the intro-
duction of broad-scale chlamydia screening:
..you need to, I guess run a media campaign similar to a lot of
the other screening media campaigns that have gone on, advis-
ing the population. And obviously you'd need to target, probably
towards the younger population. (DC16)
Quantitative component
a) Barriers
GPs considered that time constraints during the consulta-
tion was the main barrier to increased chlamydia screen-
ing. Over one third indicated that lack of a formal recall/
reminder system for chlamydia screening and lack of sup-
port for contact tracing were also barriers to increasing
chlamydia screening in general practice. (Table 2)
Respondents did not consider that concerns about over-
servicing, costs of screening to clients, difficulties in dis-
cussing sexual health issues with patients and the chance
of getting a false positive test result were barriers to
increased chlamydia screening in general practice.
b) Facilitators
Over 90% of GPs surveyed indicated that they would be
likely to increase chlamydia screening if there were
national chlamydia screening guidelines, if there was
national screening program or if there was an organised
educational program for the general public. Over 80%
would increase chlamydia screening if there was an incen-
tive payment available for each chlamydia test performed.
The majority of GPs consider that it is important to be
able to test urines rather than swabs. (Table 2)
Partner notification
Qualitative component
GPs were asked about partner notification. Over half the
GPs interviewed said that they left the responsibility of
partner notification up to the patient and some said that
they would suggest that the partner/s should come to
them for treatment or attend another clinic. Some GPs
said that they prepared a letter for patients to take to part-
ners or that they provided other documentation that
could be given to partners and a third said that they had
either never done any partner notification or that the situ-
ation had never arisen for them.
GPs were concerned about how to approach issues of
patient confidentiality in relation to partner notification:
..privacy and confidentiality are obviously, this whole area is
one that relates to that from a personal patient's point of view.
It's not something they want particularly published. So we've
really got some definite areas of difficulty based on considera-
tion of the patient's confidentiality as opposed to the community
benefit. (DC06)
They were also concerned about the sensitivity of notify-
ing partners and the potential repercussions for relation-
ships:Page 4 of 8
(page number not for citation purposes)
BMC Public Health 2008, 8:425 http://www.biomedcentral.com/1471-2458/8/425that's very touchy. If you're going to say, someone's partner has
chlamydia, how do you tell them? They'll say, you didn't get it
from me. It would be like saying, someone's got herpes. (DC03)
GPs also reflected on the skills required by GPs to respond
to the patient if a chlamydia test is positive:
..that's really the ramifications of performing the test. And I
think this is where you talk about pre and post test counselling.
So if you're going to perform the screening then you need to take
some time already to prepare the patient about what would hap-
pen if there was a positive result. (DC13)
GPs saw assistance with partner notification as a priority
if a chlamydia screening program were to be introduced.
This service should be presented in such a way so as to
minimise any perceived stigma that may be attached to a
STI:
..especially if it happens automatically where it's you know, it
happens that they do it as a routine. So people don't feel like
they're being singled out as you know, it's a public issue so it's
reasonable to trace any infectious disease, whether it's sexual or
not.(DC09)
Quantitative component
Again we found similar results using quantitative meth-
ods. GPs tend to rely on patient referral with the vast
majority indicating that they ask the patient to follow up
their contacts; about one quarter indicated that they gave
their patient a contact letter to give to their partners. A
small proportion indicated that they did nothing because
they assumed that health department undertook partner
notification when a new case of chlamydia was notified.
When asked what support or resources GPs would like to
help them with partner notification, over two thirds indi-
cated that contact letters would be helpful and about half
specified that websites or the officers employed by the
health department to assist with contact tracing would be
helpful. Interestingly, only a small proportion (7%) indi-
cated that SMS phone messages would be helpful. (Table
3)
Discussion
Our study is the first detailed qualitative study of chlamy-
dia screening in Australia and has identified a number of
issues that are important to address before chlamydia
screening is introduced widely within the Australian
health care setting. Firstly, GPs felt strongly that screening
would be easier if there was a national screening program
and if the public had a greater understanding of chlamy-
Table 2: Barriers and facilitators to increasing chlamydia screening in general practice
Barrier Probably not % (95%CI) Not sure % (95%CI) Probably % (95%CI)
Concerns about over-serving 74 (68, 80) 6 (3, 9) 20 (15, 25)
The cost of testing to the client 72 (70, 77) 7 (4, 10) 21 (16, 30)
Time constraints during the consultation 32 (26, 38) 6 (3, 9) 62 (56, 68)
Difficulty in talking with patients about sexual health issues 74 (68, 79) 8 (5, 12) 18 (13, 23)
The chance of getting a false positive result on testing 73 (67, 78) 16 (12, 21) 10 (7, 15)
Concerns that some pathology providers prefer swabs rather than urine 
specimens for chlamydia testing
67 (61, 73) 16 (12, 21) 17 (12, 22)
Patient's lack of knowledge about chlamydia 58 (51, 64) 9 (6, 13) 33 (27, 39)
Religion or ethnicity of patient 50 (43, 56) 19 (14, 24) 31 (25, 37)
Lack of a formal recall/reminder system for chlamydia testing 40 (34, 46) 19 (14, 24) 41 (35, 47)
Lack of support for partner notification/following up of the partners of 
positive cases
39 (33, 46) 22 (17, 28) 39 (33, 35)
Facilitators
If there was a recognised national chlamydia screening program 4 (2, 7) 3 (1, 6) 93 (89, 96)
If payment was available for a practice nurse to discuss chlamydia testing 
with patients and conduct the testing
21 (16, 27) 9 (6, 13) 70 (63, 75)
If there were national guidelines recommending who should be screened 
and tested for chlamydia
3 (1, 6) 5 (3, 9) 92 (87, 94)
If there was an incentive payment to GPs for each chlamydia testing 
performed
9 (6, 13) 7 (4, 11) 83 (78, 88)
If GPs had more knowledge on how to manage chlamydia infected patients 36 (30, 43) 13 (9, 18) 50 (43, 56)
If there was an organised chlamydia education program for the general 
public
4 (2, 8) 5 (3, 9) 90 (85, 93)
If there was a recall/reminder system 10 (6, 14) 13 (9, 17) 77 (71, 82)Page 5 of 8
(page number not for citation purposes)
BMC Public Health 2008, 8:425 http://www.biomedcentral.com/1471-2458/8/425dia. Secondly, they felt that incentive payments would
facilitate screening. Thirdly, greater support for contact
tracing would be important if screening is to increase.
These findings are completely in line with the views of a
recent study of Australian women we conducted that
found that women want chlamydia screening to be 'nor-
malised' – to become part of a routine health check that is
based on their current age, not their sexual history [21].
Most GPs interviewed believed that chlamydia screening
should ideally be opportunistic and offered during a sex-
ual health consultation. While linking chlamydia screen-
ing with a Pap test may make it easier for GPs to introduce
the subject of chlamydia with their patients [22], cervical
screening in Australia currently commences at age 20 and
as a result, other resources would be needed to ensure
women under 20 years of age are also screened. Further, it
is likely that the introduction of the human papilloma
virus (HPV) vaccination will lead to revisions in the
National Cervical Screening Program in Australia with the
commencement of screening being delayed to a later age
[23].
GPs completing the postal survey were more likely to
believe that an organised screening program with a system
of recall and reminders would be the preferred model for
screening in Australia rather than relying on opportunistic
screening alone. The reasons for this discrepancy between
the qualitative and quantitative results are unclear, but
differences in methodology (quantitatively with a closed
answer response versus a qualitative interview question),
may explain the difference. Nevertheless, their support for
chlamydia screening in Australia was encouraging. How-
ever, given that Australian GPs are currently screening
only about 8% of women under 25 years of age each year
[24], this suggests that although they support screening,
there must be considerable barriers to increased screening.
Mathematical modelling of chlamydia screening shows
that 20–30% of women must be screened each year to
have an impact on lowering chlamydia prevalence [25,26]
highlighting that any chlamydia screening program must
increase the proportion screened each year.
We found that GPs identified a number of important bar-
riers that must be addressed for screening to be successful.
Time was seen as the greatest barrier to increased chlamy-
dia screening. Patient embarrassment and lack of knowl-
edge about chlamydia were also mentioned as important
barriers to screening. This finding combined with our
observation above that many GPs would prefer to screen
for chlamydia in the context of a sexual health consulta-
tion, raises the possibility of prompting that all women
from age 16 have a regular women's health check that
could for example, include chlamydia and STI screening
in the younger age groups and Pap smear screening as the
women move into their mid 20s. This would normalise
chlamydia screening, by placing it in the context of a
woman's regular health maintenance. This approach has
previously been found to increase acceptability of chlamy-
dia screening amongst young women [15]. Surveys of GPs
conducted both overseas [27-29] and in Australia [30]
have also found that lack of time and fear of embarrassing
patients are commonly expressed barriers to increased
chlamydia screening by general practitioners.
GPs suggested several different facilitators for increased
screening including financial incentives for GPs; funding
for practice nurses; education for GPs, practice nurses and
the general public; national screening guidelines; and the
introduction of a formal screening program with associ-
ated recall mechanisms. In view of the low screening rates
in Australia, it is vitally important that these different
facilitators are investigated when designing Australia's
screening program [31]. Since November 2006, practice
Table 3: Partner notification practices and resources
Partner notification practices Proportion* % (95%CI)
Ask the patient to follow up their contacts 92 (88, 95)
Give the patient a contact letter to give to their contacts 23 (18, 292)
Write a letter to the patient's contacts directly 2 (0.4, 4)
Directly ask the health department partner notification officers to follow up their contacts 14 (10, 19)
Nothing – the health department does the partner notification whenever a new case of chlamydia is notified 8 (5, 12)
Partner notification resources
Partner/contact letters 70 (64, 75)
Websites 42 (36, 48)
SMS phone messages 7 (4, 10)
Telephone hotline 31 (25, 37)
Health department partner notification officers 50 (44, 56)
* Multiple responses possiblePage 6 of 8
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testing if it is undertaken concurrently with a cervical
smear (Pap test), but they are unable to conduct screening
otherwise. However, only about 55% of clinics in Aus-
tralia include a practice nurse [32] and as practice nurses
play an important role in the National Chlamydia Screen-
ing Program in the United Kingdom, further considera-
tion should be given to expanding their role in Australian
general practice [33].
Partner notification is an essential component in the con-
trol of STIs [34]. Our participants indicated they generally
leave the responsibility of partner notification to the
patient, with about one quarter indicating that they pre-
pared a letter or documentation for patients to take to
their partners. These findings are consistent with a recent
postal survey of Australian GPs which also found that the
majority of GPs believed that patients were largely respon-
sible for contacting partners [35].
Our study has a number of strengths. Firstly, it is one of
the few studies of GPs' attitudes to chlamydia screening
that has included both a qualitative and quantitative com-
ponent. The findings of the postal survey were generally in
concordance with those obtained in the qualitative inter-
views. We obtained a response rate of 47% for the postal
survey, a reasonable response for a postal survey of GPs,
particularly as reported response rates have dropped over
the last two decades [36] and a recent postal survey of GPs
in New South Wales reported a response rate of 45% [37].
There are some limitations in our study results. Firstly, the
GPs selected for the qualitative interviews may represent a
biased sample; with a response rate of 30% it is possible
that those interested in STIs were more likely to partici-
pate in the study. Secondly, female GPs and those aged 45
to 54 years were over-represented in the postal survey. As
previous surveys have shown that female GPs were more
likely to test asymptomatic patients and had a superior
knowledge about appropriate specimens for diagnosing
Chlamydia [38], it is possible that the postal survey results
may have some bias and led to an overestimation of GPs'
support for chlamydia screening. Thirdly, our sample size
of 255 was lower than the 300 calculated, reducing the
precision of our estimates slightly. Finally, this study was
conducted in Victoria and may not be generalizable to rest
of Australia. However, with the exception of remote areas,
the demographic profile of GPs is similar across the differ-
ent States of Australia [20] and the prevalence of chlamy-
dia among non-Indigenous populations across Australia
is also similar [3,39].
Conclusion
Australian GPs believe that general practice is an appropri-
ate place for chlamydia screening to take place, particu-
larly in the context of a sexual health consultation where
chlamydia could be normalised. However, if screening is
to succeed in Australia and screening rates are to increase
to the levels necessary to have an impact on the burden of
chlamydia, policy makers must investigate the facilitators
suggested here such as incentive payments, funding for
practice nurses, education campaigns and recall/reminder
mechanisms. These relatively straight forward changes
have the potential to substantially increase chlamydia
screening.
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